Adverum Biotechnologies Inc. buy Truist Financial Co.
Start price
14.08.24
/
50%
€1.38
Target price
14.08.25
€36.26
Performance (%)
-
End price
15.08.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target lowered by analysts at Truist Financial Co. from $60.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
In the thread Trading Adverum Biotechnologies Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
15.05.24
15.05.24
€55.13
15.05.25
15.05.25
-
16.05.25
16.05.25
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.62
05.09.23
05.09.23
€5.60
05.09.24
05.09.24
-17.28%
06.09.24
06.09.24